Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05181891 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

Study acronym: PERRAS
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contact updatedv6
  2. Primary completion date: May 1, 2026 to Dec 31, 2026
    • Study completion date: May 1, 2026 to May 1, 2027
    • Site contact updated
    v5
  3. Re-verified, no change to tracked fieldsv4
  4. Phase: Phase 2/3 to Phase 2v3
  5. Phase: Phase 1 to Phase 2/3v2 Show 5 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2022 to Jul 11, 2022
    • Study sites: 0 to 1
    • Primary and study completion dates: Dec 2025 to May 1, 2026
    • Eligibility criteria revised
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Using a randomized controlled trial (RCT), the goal of this study is to evaluate the ability of evidence based behavioral treatment (contingency management: CM) to significantly decrease alcohol use and cigarette smoking among treatment-seeking smokers with an alcohol use disorder (AUD) who have initiated pharmacotherapy (varenicline; VC) for smoking cessation.
Trial Details
NCT Number NCT05181891
Lead Sponsor Washington State University
Conditions
(from sponsor)		 Alcohol Use Disorder (AUD), Nicotine Use Disorder
Related terms Alcoholism, Tobacco Use Disorder
Enrollment 205 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov